Insider Trading History of Bradley Scott

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bradley Scott since 2007. The trader's CIK number is 1410520. At the time of the last reporting, Bradley Scott was the 10% Owner of Xtl Biopharmaceuticals Ltd. (stock ticker symbol XTLB). Also see all insider trading activities at Xtl Biopharmaceuticals Ltd.

Note that in the past Bradley Scott also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Optimer Pharmaceuticals Inc (OPTR) by Bradley Scott

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 OPTR 0 $0 55,800 $429,392 0 $0

Yearly summary of insider trading at Penwest Pharmaceuticals Co (PPCO) by Bradley Scott

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 PPCO 4,203,400 $20,760,361 0 $0 0 $0

Yearly summary of insider trading at Xtl Biopharmaceuticals Ltd (XTLB) by Bradley Scott

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 XTLB 28,424,120 $94,357,358 0 $0 0 $0
2007 XTLB 300,000 $778,500 0 $0 0 $0


Insider trading activities at 3 companies by Bradley Scott:

1. Optimer Pharmaceuticals Inc (OPTR)

2. Penwest Pharmaceuticals Co (PPCO)

3. Xtl Biopharmaceuticals Ltd (XTLB)

Table 1. Insider trading of Optimer Pharmaceuticals Inc (OPTR) by Bradley Scott

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-12-17 OPTR Sale 12,600 7.71 97,146
2007-12-18 OPTR Sale 24,400 7.71 188,197
2007-12-19 OPTR Sale 12,220 7.75 94,680
2007-12-13 OPTR Sale 6,580 7.50 49,369

Table 2. Insider trading of Penwest Pharmaceuticals Co (PPCO) by Bradley Scott

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-05-15 PPCO Buy 2,500 5.00 12,500
2008-05-07 PPCO Buy 2,500 5.00 12,500
2008-03-20 PPCO Buy 1,340,300 5.83 7,817,969
2008-03-10 PPCO Buy 342,200 6.67 2,281,105
2008-03-18 PPCO Buy 800 7.50 6,000
2008-03-12 PPCO Buy 7,400 5.00 37,000
2008-03-11 PPCO Buy 1,937,900 4.04 7,829,116
2008-03-05 PPCO Buy 52,100 5.00 260,500
2008-03-04 PPCO Buy 13,600 5.00 68,000
2008-02-20 PPCO Buy 600 7.50 4,500
2008-02-19 PPCO Buy 1,500 7.50 11,250
2008-02-12 PPCO Buy 5,000 4.14 20,690
2008-02-01 PPCO Buy 42,000 5.34 224,196
2008-01-31 PPCO Buy 160,000 4.97 795,680
2008-01-30 PPCO Buy 170,000 4.74 806,480
2008-01-29 PPCO Buy 125,000 4.58 572,875

Table 3. Insider trading of Xtl Biopharmaceuticals Ltd (XTLB) by Bradley Scott

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-06-10 XTLB Buy 51,000 3.23 164,730
2008-06-05 XTLB Buy 300,000 3.26 977,999
2008-06-06 XTLB Buy 100,000 3.43 343,000
2008-06-09 XTLB Buy 33,600 3.36 112,896
2008-06-04 XTLB Buy 25,000 2.99 74,750
2008-06-03 XTLB Buy 400,730 3.03 1,214,211
2008-05-02 XTLB Buy 50,000 3.88 194,000
2008-05-01 XTLB Buy 105,000 3.75 393,750
2008-04-01 XTLB Buy 301,000 3.16 951,762
2008-04-01 XTLB Buy 301,000 3.16 951,762
2008-04-01 XTLB Buy 301,000 3.16 951,762
2008-03-28 XTLB Buy 25,000 2.90 72,450
2008-03-18 XTLB Buy 163,000 3.12 508,560
2008-03-14 XTLB Buy 463,000 3.33 1,539,938
2008-03-12 XTLB Buy 26,400 3.36 88,651
2008-03-13 XTLB Buy 14,820 3.38 50,032
2008-03-13 XTLB Buy 232,180 3.38 783,839
2008-03-12 XTLB Buy 413,600 3.36 1,388,868
2008-03-11 XTLB Buy 619,000 3.31 2,047,652
2008-03-10 XTLB Buy 1,420,000 3.22 4,578,080
2008-03-07 XTLB Buy 1,150,460 3.69 4,247,498
2008-03-06 XTLB Buy 915,000 3.79 3,472,425
2008-03-05 XTLB Buy 570,000 3.94 2,244,660
2008-03-04 XTLB Buy 410,700 3.98 1,636,639
2008-02-25 XTLB Buy 875,000 3.86 3,381,000
2008-02-22 XTLB Buy 1,173,000 3.95 4,632,177
2008-02-26 XTLB Buy 463,180 3.93 1,818,907
2008-02-13 XTLB Buy 6,000 3.81 22,848
2008-02-06 XTLB Buy 352,000 3.69 1,300,640
2008-02-07 XTLB Buy 10,000 3.40 33,960
2008-02-04 XTLB Buy 690,000 3.87 2,673,060
2008-02-05 XTLB Buy 252,000 3.77 949,536
2008-02-01 XTLB Buy 700,000 3.69 2,583,700
2008-01-31 XTLB Buy 894,000 3.47 3,098,604
2008-01-30 XTLB Buy 250,000 3.23 807,500
2008-01-28 XTLB Buy 680,000 3.22 2,190,960
2008-01-29 XTLB Buy 100,000 3.23 322,900
2008-01-25 XTLB Buy 200,000 3.24 647,600
2008-01-25 XTLB Buy 200,000 3.24 647,600
2008-01-24 XTLB Buy 338,570 2.98 1,010,631
2008-01-23 XTLB Buy 300,000 2.88 864,900
2008-01-24 XTLB Buy 338,570 2.98 1,010,631
2008-01-23 XTLB Buy 300,000 2.88 864,900
2008-01-15 XTLB Buy 950,000 3.09 2,931,700
2008-01-22 XTLB Buy 13,310 2.90 38,625
2008-01-18 XTLB Buy 323,000 3.14 1,015,512
2008-01-17 XTLB Buy 345,000 3.03 1,045,349
2008-01-16 XTLB Buy 463,000 3.12 1,443,171
2008-01-16 XTLB Buy 463,000 3.13 1,448,264
2008-01-15 XTLB Buy 950,000 3.09 2,931,700
2008-01-14 XTLB Buy 370,000 3.41 1,262,070
2008-01-11 XTLB Buy 472,000 3.39 1,601,024
2008-01-07 XTLB Buy 1,660,000 3.02 5,019,840
2008-01-08 XTLB Buy 30,000 3.26 97,740
2008-01-09 XTLB Buy 1,001,000 3.29 3,288,285
2007-01-08 XTLB Buy 470,000 3.26 1,531,260
2008-01-10 XTLB Buy 1,150,000 3.30 3,795,000
2008-01-02 XTLB Buy 1,222,000 2.89 3,531,580
2007-01-02 XTLB Buy 78,000 2.89 225,420
2007-12-31 XTLB Buy 1,150,000 2.73 3,145,250
2007-12-28 XTLB Buy 800,000 2.69 2,153,600
2007-12-27 XTLB Buy 300,000 2.60 778,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bradley Scott (10% Owner of Xtl Biopharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.